Activation of β-catenin signaling and its cross talk with estrogen and histone deacetylases in human uterine fibroids.
Uterine Fibroid (UF) is the most common benign tumor in myometrium (MM) of reproductive age women. However, mechanism underlying disease pathogenesis is largely unknown. To explore the link between nuclear β-catenin and UF phenotype and β-catenin cross-talk with estrogen and histone deacetylases (HDACs). protein/RNA levels of β-catenin (CTNNB1), its responsive markers [CyclinD1, c-Myc], Androgen receptor (AR), p27 and class-I HDACs were measured in matched UF/MM tissues or cell populations. Chemical inhibition/activation and genetic knockdown (KD) of CTNNB1 were performed and their effects on UF phenotype were measured. Anti-UF Effect of two HDAC inhibitors (HDACis) was evaluated. β-catenin nuclear translocation in response to β-catenin inhibition/activation, estrogen and HDACis in UF cells. UF tissues/cells showed significantly higher expression of nuclear β-catenin, CyclinD1, C-Myc, and HDACs (1, 2, 3, 8) than MM. Estradiol induced β-catenin nuclear-translocation and consequently its responsive genes in both MM and UF cells, while Estrogen receptor antagonist reversed this induction effect. Treatment with β-catenin or HDAC inhibitors showed a dose dependent growth inhibition, while Wnt3a treatment increased proliferation compared to control. Chemical inhibition of β-catenin decreased CyclinD1 and c-Myc expression levels, while β-catenin activation increased same markers expression. Genetic KD of CTNNB1 resulted in marked decrease in β-catenin, CyclinD1, C-Myc and AR expression. Treatment of UF cells with HDACis decreased nuclear β-catenin, CyclinD1 and C-Myc expression. Moreover, HDACis induced UF cells apoptosis and cell cycle arrest. β-catenin nuclear-translocation contributes to UF phenotype, β-catenin signaling is modulated by estradiol and HDAC activity.